Delivery Order SPE2DB24D1021-SPE2DB25FFAMW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in a quantity of 100 units. This firm fixed-price delivery order, issued on June 16, 2025, carries a ceiling value of $2,450.08 and is scheduled for completion by June 17, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a non-competitive, non-set-aside delivery order and is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,253.88 to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This competitive delivery order, which was not set-aside for any socioeconomic category, was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, under firm fixed-price terms. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,288.63 on July 25, 2025, for the supply of Nucynta Tabs 50mg under a firm fixed price contract. This non-set-aside award is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by July 28, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,862.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nucynta (tapentadol) 100 mg tablets in a 100-count package. This competitively awarded, non-set-aside contract will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. The delivery order represents a child contract action under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $1,929.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta (tapentadol) 50 mg, with an ultimate completion date of June 17, 2025. This non-set-aside competitive award leverages AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical...
- On June 2, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,350.24 to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100. This firm fixed-price delivery order, with an ultimate completion date of June 3, 2025, represents a continuation of the company's extensive pharmaceutical support to the Department of Defense medical procurement system. The award is non-competitive with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,494.98 to AmerisourceBergen Drug Corp for 100 tablets of Nucynta (tapentadol) 50 mg, with an ultimate completion date of September 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs....
- The Defense Logistics Agency Medical Supply Chain awarded a $4,442.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nucynta (tapentadol) 50mg tablets. This non-set-aside delivery order, with an ultimate completion date of August 12, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,694.17 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary distribution...
- This $6,718.16 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of NUCYNTA (tapentadol) 50mg tablets, a prescription pain medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAMWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This firm fixed price delivery order, valued at $2,384.48, was competitively awarded without set-aside restrictions and is scheduled for completion by September 11, 2025. The award represents a child contract under AmerisourceBergen's larger relationship with the DLA and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls within AmerisourceBergen's extensive portfolio of pharmaceutical supply contracts with the Defense Logistics Agency, which includes a prime indefinite delivery contract valued at $999,999,999.00 through December 2026. The company serves as a critical vendor for federal medical procurement, supplying pain management pharmaceuticals, specialty medications, and other healthcare commodities to support military and veteran healthcare systems. The award demonstrates AmerisourceBergen's capacity to fulfill federal pharmaceutical requirements through open competition and its role in the DLA's broader Medical Supply Chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/10/25 |